Synchron Inc., a competitor to Elon Musk‘s Neuralink Corp. backed by Jeff Bezos and Bill Gates, has revealed plans to extend its brain-device technology to treat conditions such as epilepsy and Parkinson’s disease.
What Happened: On Thursday at the Bloomberg Tech Summit, Synchron’s founder, Tom Oxley, disclosed the company’s expansion strategy saying that it intends to adapt…

#synchroninc#jeffbezos#billgates#bloombergtechsummit#synchron#tomoxley#stentrode#apple